|
NRIX
|
Nurix Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NVCT
|
Nuvectis Pharma, Inc.
|
US
|
NASDAQ
|
|
ONCT
|
Oncternal Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ONCY
|
Oncolytics Biotech Inc.
|
US
|
NASDAQ
|
|
ORIC
|
Oric Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PRPO
|
Precipio, Inc.
|
US
|
NASDAQ
|
|
RAPT
|
RAPT Therapeutics, Inc.
|
US
|
NASDAQ
|
|
RNA
|
Avidity Biosciences, Inc.
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
US
|
NASDAQ
|
|
SRNE
|
Sorrento Therapeutics, Inc.
|
US
|
NASDAQ
|
|
STTK
|
Shattuck Labs, Inc.
|
US
|
NASDAQ
|
|
TGTX
|
TG Therapeutics, Inc.
|
US
|
NASDAQ
|
|
TNGX
|
Tango Therapeutics
|
US
|
NASDAQ
|
|
VINC
|
Vincera Pharma, Inc.
|
US
|
NASDAQ
|
|
VKTX
|
Viking Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ALA
|
Arovella Therapeutics Limited
|
AU
|
ASX
|
|
CU6
|
Clarity Pharmaceuticals Ltd
|
AU
|
ASX
|
|
PAB
|
Patrys Limited
|
AU
|
ASX
|
|
AVXT
|
Avax Techs Inc
|
US
|
OTC
|
|
BIEI
|
Premier Biomedical
|
US
|
OTC
|